Pyogenic Granuloma Management and Clinical Insights
Summary
Pyogenic granuloma is a common, benign vascular lesion affecting both skin and mucous membranes worldwide. Clinically, it presents as a rapidly enlarging, erythematous nodule prone to bleeding even after minor trauma. Although its precise aetiology remains elusive, contributions from hormonal fluctuations, local irritation, drug exposure and molecular alterations such as BRAF mutations have been identified. Definitive diagnosis hinges on clinicopathological correlation, distinguishing the lobular capillary haemangioma subtype from non-lobular variants. Management strategies are tailored to lesion characteristics and patient factors: surgical excision with adequate margins remains the mainstay, often enhanced by laser ablation or cryotherapy to achieve haemostasis and reduce recurrence. Minimally invasive alternatives, notably sclerotherapy and topical or systemic beta-adrenergic receptor antagonists, have gained traction as first-line options in paediatric, periungual and ocular settings. Recurrence rates vary with technique, underscoring the importance of individualised follow-up protocols. Advances in imaging, histomorphometry and molecular profiling are refining diagnostic precision and paving the way for targeted therapeutics. Interdisciplinary collaboration across dermatology, dentistry and ophthalmology has enriched the therapeutic armamentarium, improving functional outcomes and patient quality of life. The global burden of pyogenic granuloma, its propensity for disfiguring haemorrhage and potential impact on daily activities highlight the ongoing need for research into pathogenesis, risk stratification and optimised management pathways.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Pyogenic Granuloma Management and Clinical Insights publication trend
The graph below shows the total number of articles in pyogenic granuloma management and clinical insights across all publications each year (not limited to Nature Index journals).
Technical terms
Pyogenic granuloma: A benign vascular proliferation characterised by rapid growth, rich capillary networks and a marked tendency to bleed.
Lobular capillary haemangioma: A histological variant of pyogenic granuloma distinguished by organised lobular clusters of capillaries within a fibromyxoid stroma.
Sclerotherapy: A minimally invasive procedure involving injection of a sclerosant agent to induce endothelial damage and lesion regression.
Diode laser: A semiconductor-based light source used for precise vascular lesion excision and coagulation with minimal collateral damage.
Beta-adrenergic receptor antagonist: A class of agents, including timolol and propranolol, that inhibit vascular proliferation and angiogenesis when applied topically or systemically.
References
- Oral Pyogenic Granuloma: A Narrative Review. International Journal of Molecular Sciences (2023).
- Comparative Evaluation of Efficacy and Safety of the Diode Laser (980 nm) and Sclerotherapy for the Treatment of Oral Pyogenic Granuloma. International Journal of Dentistry (2022).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.